Bristol OTC Stock Performance

BMYMP
 Stock
  

USD 1,300  21.00  1.59%   

Bristol Myer has a performance score of 9 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.0661, which signifies not very significant fluctuations relative to the market. Let's try to break down what Bristol's beta means in this case. As returns on the market increase, Bristol Myer returns are expected to increase less than the market. However, during the bear market, the loss on holding Bristol Myer will be expected to be smaller as well. Although it is important to respect Bristol Myer Squi historical returns, it is better to be realistic regarding the information on the equity's current trending patterns. The philosophy towards foreseeing future performance of any stock is to evaluate the business as a whole together with its past performance, including all available fundamental and technical indicators. By analyzing Bristol Myer Squi technical indicators, you can presently evaluate if the expected return of 0.15% will be sustainable into the future. Bristol Myer Squi right now shows a risk of 1.16%. Please confirm Bristol Myer Squi information ratio, as well as the relationship between the potential upside and kurtosis to decide if Bristol Myer Squi will be following its price patterns.
  
Refresh
Bristol Performance
9 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Bristol Myer Squi are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain primary indicators, Bristol Myer may actually be approaching a critical reversion point that can send shares even higher in August 2022. ...more

Structure and Payout Changes

Forward Annual Dividend Yield
0.0012
Payout Ratio
0.029
Dividend Date
2022-09-01

Bristol Price Channel

Fifty Two Week Low999.50
Fifty Two Week High2,000.00
Trailing Annual Dividend Yield0.12%

Bristol Myer Relative Risk vs. Return Landscape

If you would invest  119,100  in Bristol Myer Squi on April 5, 2022 and sell it today you would earn a total of  10,900  from holding Bristol Myer Squi or generate 9.15% return on investment over 90 days. Bristol Myer Squi is currently producing 0.1479% returns and takes up 1.1594% volatility of returns over 90 trading days. Put another way, 10% of traded otc stocks are less volatile than Bristol, and 98% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
 Daily Expected Return (%) 
      Risk (%) 
Assuming the 90 days horizon Bristol Myer is expected to generate 0.8 times more return on investment than the market. However, the company is 1.25 times less risky than the market. It trades about 0.13 of its potential returns per unit of risk. The DOW is currently generating roughly -0.11 per unit of risk.

Bristol Myer Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Bristol Myer's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Bristol Myer Squi, and traders can use it to determine the average amount a Bristol Myer's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.1275

Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small Returns
CashBMYMPAverage
Risk
High
Risk
Huge
Risk
Negative Returns
Estimated Market Risk
 1.16
  actual daily
 
 10 %
of total potential
 
1010
Expected Return
 0.15
  actual daily
 
 2 %
of total potential
 
22
Risk-Adjusted Return
 0.13
  actual daily
 
 9 %
of total potential
 
99
Based on monthly moving average Bristol Myer is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bristol Myer by adding it to a well-diversified portfolio.

About Bristol Myer Performance

To evaluate Bristol Myer Squi OTC Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Bristol Myer generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Bristol OTC Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Bristol Myer Squi stock market performance in a much more refined way. At Macroaxis, we take it even further. The Macroaxis performance score is an integer between 0 and 100 that represents Bristol's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, and distributes biopharmaceutical products worldwide. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York. Bristol Myers operates under Drug Manufacturers - Major classification in USA and is traded on OTC Market. It employs 23700 people.

Things to note about Bristol Myer Squi

Checking the ongoing alerts about Bristol Myer for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Bristol Myer Squi help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Continue to Trending Equities. Note that the Bristol Myer Squi information on this page should be used as a complementary analysis to other Bristol Myer's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Fund Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Complementary Tools for Bristol OTC Stock analysis

When running Bristol Myer Squi price analysis, check to measure Bristol Myer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myer is operating at the current time. Most of Bristol Myer's value examination focuses on studying past and present price action to predict the probability of Bristol Myer's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Bristol Myer's price. Additionally, you may evaluate how the addition of Bristol Myer to your portfolios can decrease your overall portfolio volatility.
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Is Bristol Myer's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bristol Myer. If investors know Bristol will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bristol Myer listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
2131.9 B
The market value of Bristol Myer Squi is measured differently than its book value, which is the value of Bristol that is recorded on the company's balance sheet. Investors also form their own opinion of Bristol Myer's value that differs from its market value or its book value, called intrinsic value, which is Bristol Myer's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bristol Myer's market value can be influenced by many factors that don't directly affect Bristol Myer's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bristol Myer's value and its price as these two are different measures arrived at by different means. Investors typically determine Bristol Myer value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bristol Myer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.